Kishiki, T., Ohnishi, H., Masaki, T., Ohtsuka, K., Ohkura, Y., Furuse, J., . . . Sugiyama, M. (2014). Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS. Springer Berlin Heidelberg.
Citação norma ChicagoKishiki, Tomokazu, Hiroaki Ohnishi, Tadahiko Masaki, Kouki Ohtsuka, Yasuo Ohkura, Jyunji Furuse, Takashi Watanabe, and Masanori Sugiyama. Overexpression of MET Is a New Predictive Marker for Anti-EGFR Therapy in Metastatic Colorectal Cancer With Wild-type KRAS. Springer Berlin Heidelberg, 2014.
Citação norma MLAKishiki, Tomokazu, et al. Overexpression of MET Is a New Predictive Marker for Anti-EGFR Therapy in Metastatic Colorectal Cancer With Wild-type KRAS. Springer Berlin Heidelberg, 2014.